SABS: SAB Biotherapeutics, Inc. Stock

by  •  • Comments Off on SABS: SAB Biotherapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 12.91
Enterprise Value ($M) 4.29
Book Value ($M) 25.97
Book Value / Share 2.80
Price / Book 0.50
NCAV ($M) 5.57
NCAV / Share 0.60
Price / NCAV 2.32

Profitability (mra)
Return on Invested Capital (ROIC) -1.11
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.65

Liquidity (mrq)
Quick Ratio 2.98
Current Ratio 2.98

Balance Sheet (mrq) ($M)
Current Assets 23.79
Assets 44.20
Liabilities 18.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.32
Operating Income -42.91
Net Income -34.11
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -34.29
Cash from Investing -11.96
Cash from Financing -1.17

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Rtw Investments, Lp 9.99 -88.89

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-31 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 571 845 67.57
2025-04-16 13,282 28,182 47.13
2025-04-15 8,241 11,935 69.05
2025-04-14 2,966 7,434 39.90

(click for more detail)

Similar Companies
RNXT – RenovoRx, Inc. RVPH – Reviva Pharmaceuticals Holdings, Inc.
RZLT – Rezolute, Inc. SAVA – Cassava Sciences, Inc.
SBFM – Sunshine Biopharma, Inc.


Financial data and stock pages provided by
Fintel.io